Clin2
NCT07663032Possibly a fitRecruiting

Pan-Salmonella vaccine study for healthy young adults

Salmonella Infections

Part of Infections clinical trials.

This trial tests an experimental vaccine designed to protect against multiple types of Salmonella bacteria (which cause typhoid fever and other infections). It is given to healthy adults aged 18 to 45 to check safety and immune response.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
196 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are 18 to 45 years old
  • You are generally healthy (no serious medical conditions or immune problems)
  • You have not had a typhoid vaccine or similar Salmonella vaccine before
  • You are not pregnant or breastfeeding, and use effective birth control if needed
  • You have a negative HLA-B27 test (a genetic test) and a body mass index between 18 and 30
  • You are willing to stay in the study area for the whole study and follow visit schedule

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07286370Recruiting· Phase 2
Vaccine study for typhoid and salmonella in infants

This study tests a new vaccine that could protect infants against typhoid fever and a serious type of salmonella. If your baby is healthy and within the age range, they may be eligible to participate.

Banjul
NCT07416461Recruiting
Malaria vaccine study for reducing Salmonella risk

This study looks at whether malaria vaccines can also help lower the risk of a serious bacterial infection called invasive non-typhoidal Salmonella (iNTS). If you have a fever, you may be able to join and help researchers understand this connection.

Kinshasa
NCT07509047Recruiting· Phase 2
Cholera vaccine safety study for adults and children

This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.

Nairobi, Kenyatta National Hospital Complex
NCT07107516Recruiting· Phase 1
Testing an oral cholera vaccine in healthy adults

This study tests an oral cholera vaccine called PanChol in healthy adults. The goal is to see if it's safe and how the body responds. It may help protect against cholera, a serious diarrheal illness.

Lusaka, Lusaka Province
NCT07085702Recruiting· Phase 1
Testing a new Strep A vaccine in healthy young adults

This study tests a new vaccine designed to protect against Group A Strep bacteria. It will check how safe the vaccine is and how well it boosts your immune system. Healthy young adults between 18 and 25 years old may be eligible.

Botany, New South Wales
NCT07122986Recruiting· Phase 1
Testing a new E. coli vaccine in healthy adults

This study tests an experimental vaccine designed to protect against E. coli bacteria. It is for healthy adults aged 18 to 63 who want to help researchers see if the vaccine is safe and produces an immune response.

Anaheim, California

Hear when a new Salmonella Infections trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.